Search Results - siva+koganti

1 Results Sort By:
11-Gene Panel That Predicts if a Cancer Will Respond to Synthetic-Lethal Therapies
Identifies a Wide Range of Cancers That Will Succumb to PARP Inhibitors Already Used Successfully in Ovarian and Breast Cancer This STAT3-induced 11-gene signature can predict which cancers will respond to synthetic lethal therapies, such as poly ADP-ribose polymerase (PARP) inhibitors that have been successfully used in ovarian and breast cancer....
Published: 9/23/2021   |   Inventor(s): Sumita Bhaduri-McIntosh, Michael McIntosh, Siva Koganti, Xiaofan Li
Keywords(s):  
Category(s): Technology Classifications > Human Health Care > Therapeutics, Technology Classifications > Medical Devices > Others